HECHT BETH (See Remarks) sold 1.2% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $116.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2025ACC: 0001652410-25-000005
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$116.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$7.01
Trade value
$116.78K
% of position
1.2%
12/1/2025
1.34M→1.32M
Total
Net shares
−16.67K
Net value
-$116.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | S · Sale | −16.67K | $7.01 | $116.78K | 1.2% | 1.34M | 1.32M |
| Total | −16.67K | -$116.78K | ||||||
Derivative Transactions0
No derivative transactions reported